TA
Tamarack Advisers Portfolio holdings
AUM
$2.12M
1-Year Return
56.28%
This Quarter Return
-9.95%
1 Year Return
-56.28%
3 Year Return
-45.76%
5 Year Return
+44.93%
10 Year Return
–
AUM
$172M
AUM Growth
-$36.9M
(-18%)
Cap. Flow
-$4.52M
Cap. Flow
% of AUM
-2.63%
Top 10 Holdings %
Top 10 Hldgs %
57.79%
Holding
56
New
11
Increased
13
Reduced
11
Closed
13
Top Buys
| 1 |
Perrigo
PRGO
|
$8.11M |
| 2 |
United Therapeutics
UTHR
|
$7.07M |
| 3 |
Labcorp
LH
|
$5.86M |
| 4 |
Amgen
AMGN
|
$5.84M |
| 5 |
MDRX
Veradigm Inc. Common Stock
MDRX
|
$5.19M |
Top Sells
| 1 |
Medtronic
MDT
|
$8.32M |
| 2 |
Merck
MRK
|
$7.29M |
| 3 |
CVS Health
CVS
|
$5.06M |
| 4 |
Exelixis
EXEL
|
$4.53M |
| 5 |
Gilead Sciences
GILD
|
$4.46M |
Sector Composition
| 1 | Healthcare | 95.35% |
| 2 | Consumer Staples | 2.99% |
| 3 | Technology | 0.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SLGC
26
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
| $1.58M | 0.92% |
350,000
+55,000
| +19% | +$249K |
|
27
Ascendis Pharma
ASND
$12.2B
| $1.39M | 0.81% |
+15,000
| New | +$1.39M |
|
28
Tactile Systems Technology
TCMD
$300M
| $1.28M | 0.74% |
175,000
+52,244
| +43% | +$382K |
|
29
DocGo
DCGO
$146M
| $1.25M | 0.72% |
175,000
+65,000
| +59% | +$464K |
|
30
InMode
INMD
$914M
| $1.12M | 0.65% |
50,000
-80,000
| -62% | -$1.79M |
|
|
VRAY
31
DELISTED
ViewRay, Inc.
VRAY
| $1.06M | 0.61% |
400,000
-200,000
| -33% | -$530K |
|
|
NXGN
32
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $1.05M | 0.61% |
60,000
+10,000
| +20% | +$174K |
|
33
RadNet
RDNT
$5.56B
| $864K | 0.5% |
50,000
| – | – |
|
|
DMTK
34
DELISTED
DermTech, Inc. Common Stock
DMTK
| $554K | 0.32% |
100,000
+50,000
| +100% | +$277K |
|
35
CareDx
CDNA
$686M
| $537K | 0.31% |
+25,000
| New | +$537K |
|
36
Plexus
PLXS
$3.71B
| $471K | 0.27% |
6,000
+1,000
| +20% | +$78.5K |
|
|
SLGCW
37
DELISTED
SomaLogic, Inc. Warrant
SLGCW
| $15K | 0.01% |
+20,000
| New | +$15K |
|
38
AdaptHealth
AHCO
$1.23B
| – | – |
-20,000
| Closed | -$321K |
|
39
Baxter International
BAX
$12.1B
| – | – |
0
| – | – |
|
40
BioCryst Pharmaceuticals
BCRX
$1.74B
| – | – |
-125,000
| Closed | -$2.03M |
|
|
41
CVS Health
CVS
$93.1B
| – | – |
-50,000
| Closed | -$5.06M |
|
|
42
Exelixis
EXEL
$9.94B
| – | – |
-200,000
| Closed | -$4.53M |
|
|
43
Gilead Sciences
GILD
$140B
| – | – |
-75,000
| Closed | -$4.46M |
|
44
SPDR Gold Trust
GLD
$110B
| – | – |
0
| – | – |
|
45
Hologic
HOLX
$14.7B
| – | – |
-15,000
| Closed | -$1.15M |
|
46
Henry Schein
HSIC
$8.22B
| – | – |
-50,000
| Closed | -$4.36M |
|
|
47
Medtronic
MDT
$120B
| – | – |
-75,000
| Closed | -$8.32M |
|
48
iShares S&P 100 ETF
OEF
$22.2B
| – | – |
0
| – | – |
|
49
SPDR S&P 500 ETF Trust
SPY
$660B
| – | – |
0
| – | – |
|
50
UnitedHealth
UNH
$281B
| – | – |
-4,000
| Closed | -$2.04M |
|